Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATVAS: Rosuvastatin for Subclinical Atherosclerosis in ANCA-Associated Vasculitis
NCT02117453Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2014
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in atherosclerosis, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02117453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117453.